Cabozantinib

From WikiMD.org
Jump to navigation Jump to search

Cabozantinib

Cabozantinib (pronounced as ka-bo-zan-ti-nib) is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2. It is used in the treatment of various types of cancer, including renal cell carcinoma and hepatocellular carcinoma.

Etymology

The name "Cabozantinib" is derived from the abbreviation of the chemical name CAlcium BOrate ZANthate TItanium NIBble.

Usage

Cabozantinib is used to treat certain types of cancer (such as kidney cancer, thyroid cancer, and liver cancer). It works by slowing or stopping the growth of cancer cells.

Side Effects

Common side effects of Cabozantinib include fatigue, decreased appetite, diarrhea, nausea, and hand-foot syndrome. More serious side effects may include hypertension, bleeding, blood clots, and perforations in the stomach or intestines.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski